Market leading manufacturer and distributor of disposable hospital curtainsLONDON – Beringea, the growth capital investor that manages the Proven Venture Capital Trusts, announces that it has invested £3 million in Disposable Cubicle Curtains Limited (DCCL), trading as All in One Medical.  DCCL manufactures and distributes an evolving range of patented, best in class, disposable curtains and blinds which actively destroy deadly and harmful pathogens.  Distributed to medical institutions, DCCL’s products are manufactured and shipped from its manufacturing plant in Wolverhampton, UK. Part of Beringea’s investment was used by DCCL to acquire the anti-microbial biocide manufacturer Fantex UK Limited. Fantex is developing biodegradable biocides, with an exceptionally fast kill rate, for a number of applications outside of the healthcare industry including the retail sector, and are in negotiations with several high street retailers. Beringea Partner, Stephane Mery, who led the transaction commented:  “I am thrilled with our investment, and to be supporting such a great team.

I am also delighted that our investment is helping a British company bring its manufacturing back to the UK. DCCL’s highly specialised plant in Wolverhampton allows the Company to successfully outperform Chinese manufacturers on both quality and price. ”Hospital Acquired Infections that cross infect patients, their carers and visitors to hospitals have become a global public health issue. A typical fabric cubicle curtain that surrounds a hospital bed has a high probability of having developed on its surface pathogens such as MRSA, ECOLI, VRE, or CDIFF. As a result, in certain A&E wards, curtains must be changed and cleaned up to 20x per annum. The replacement of traditional linen products with disposable, anti-microbial curtains, assists medical institutions in preventing and combating the outbreak of infectious diseases amongst patients, staff and visitors. Demand for infection preventative medical products is also being driven by the increasing imposition of financial penalties by governments on hospitals that fail to meet minimum standards of hygiene and whose cross infection rates are deemed unacceptable.  

John Hawkins, Chairman and CEO of All in One commented: “The disposable curtain market is rapidly growing here in the UK and abroad, and with the investment by Beringea, we are in a position to achieve global market leadership. The acquisition of Fantex allows us to provide a broad spectrum of highly effective pathogen and bacteria eliminating products, applicable across a wide variety of applications, for example keeping fabrics fresh, clean and odourless.” ***For media enquiries please contact Beringea, T: +44 (0) 20 7845 7820Notes to Editors About BeringeaBeringea is an international growth capital firm with offices in London and Michigan, which invests in high growth companies. Beringea’s London office manages a number of funds, including the ProVen VCTs. Beringea is a generalist investor with sector expertise in Media, Healthcare and Retail. Beringea’s previous investments have included Fjordnet, Espresso Education, Saffron Digital and Mergermarket. Beringea LLP is authorised and regulated by the Financial Conduct Authority.About the ProVen VCTsThe ProVen VCTs (ProVen VCT, ProVen Growth & Income VCT and ProVen Planned Exit VCT) are funds raised under the government’s Venture Capital Trust scheme for supporting UK SMEs with equity investment.

Disposable Cubicle Curtains Ltd Furniture and Office | SummaryDCCL is one of the leading suppliers of disposable cubicle curtains in the UK, with more than 5 years' experience in the field.laithes curtains DCCL invented the Easy-fit disposable curtain that is tested and proven to kill 100% of MRSA on contact, and that can be put up in less than 60 seconds� releasing time to care.montgomery rhianna curtains DCCL aims to meet the needs and infection control requirements of NHS Trusts, private hospitals, doctor�s surgeries and health centres throughout the UK.lahood curtains auckland DCCL products include the patented Easy-fit curtain with stalk, Uni-fit curtain with eyelets and the NEW Claw-hook used in conjunction with the Uni-fit.

All in One Medical a trading name of DCCL was founded in 2003 with the aim of bringing to market an innovative, high quality, and highly effective disposable and biocidal products. This mission was achieved with the patenting of our unique product, and successful installation and trials in a number of leading hospital trusts in the UK. All in One Medical (A DCCL company) DCCL gained recognition for this accomplishment by winning the UK’s most prestigious corporate accolade, a Queen’s Award for Enterprise Innovation 2009 for our patented disposable curtain. Our range of products are designed to deploy our advanced anti-microbial defences at as many touch-points as possible in large and small hospitals, GP surgeries, medical centres, clinics and at home. We work with our healthcare partners to provide a safe haven for patients and staff saving money by providing the best in class product at the best price. All in One Medical believes that the primary way to reduce the risk of infection is to focus on protecting the patient at every touch point, at every stage of the journey from their home, throughout diagnosis, treatment, admission and after discharge .

A protected patient can be a full participant in their own healthcare and recovery. Our range of products is designed to deploy our advanced anti-microbial defences at as many touch-points as possible at home, in hospitals, GP Surgeries and other Medical Centres and Clinics. Our aim is to surround patients, staff and visitors with additional protection through the use of our soft furnishings, wall coverings and cleaning products. We aim to make a real difference, by helping our customers reducing the rate of infection, and by saving lives. Do contact us, so that together we can help your organisation make the case for adopting All in One Medical as a trusted supplier of effective and cost reducing Infection Control products. Subscribe To RSS Feed White House Opts For A Gigantic Arctic Research San Diego County's Mountain Regions And Towns Now Covered With Snow Meet Carlson-Wee, The 27-Year Old Millionaire Out Of Cryptocurrencies UK-based Beringea invests £3M in Disposable Cubicle Curtains Limited

Beringea has backed Disposable Cubicle Curtains Limited or DCCL with a £3 million investment, a statement about the funding said. Beringea is a growth capital firm that runs the Proven Venture Capital Trusts while DCCL is a disposable curtains and blinds maker that trades under the name All in One Medical. DCCL's products are patented and actively eliminate toxic and dangerous pathogens. Its curtains and blinds are made and shipped from its Wolverhampton, UK manufacturing facility, the statement said. DCCL used a portion of the proceeds of Beringea's funding to buy Fantex UK Limited. An anti-microbial biocide maker, Fantex is coming up with biodegradable biocides that can kill pathogens very quickly to be used in sectors outside healthcare. Fantex is currently negotiating with high street retailers for the product, the statement said. In the statement, Beringea Partner Stephane Mery said, "I am thrilled with our investment, and to be supporting such a great team. DCCL's highly specialised plant in Wolverhampton allows the Company to successfully outperform Chinese manufacturers on both quality and price."

Mery led the current deal. Patients, caregivers and their visitors in hospitals can be infected with hospital acquired infections which have become a worldwide public health concern. A regular fabric cubicle curtain covering a hospital bed has a greater likelihood of developing pathogens on its surface. Because of these deadly bacteria, fabric curtains used in some A&E wards must be changed and cleaned to as many as 20 times in a year. By replacing these linen curtains with anti-microbial and disposable ones, hospitals can avoid an infectious disease outbreak, the statement said. All in One Chairman and CEO John Hawkins said in the statement, "The disposable curtain market is rapidly growing here in the UK and abroad, and with the investment by Beringea, we are in a position to achieve global market leadership. The acquisition of Fantex allows us to provide a broad spectrum of highly effective pathogen and bacteria eliminating products, applicable across a wide variety of applications, for example keeping fabrics fresh, clean and odourless."